atovaquone/proguanil (Malarone)

Indications

• treatment of chloroquine-resistant malaria, including Plasmodium falciparum & Plasmodium vivax
• prevention of malaria (chloroquine-resistant)

Dosage

• 1 tab/day starting 1-2 days before entering endemic area, continuing for 7 days after return
• pediatric tablet is available for children

More general terms

• pharmacologic combination

Additional terms

• malaria

Components

• atovaquone (Mepron)
• proguanil (Chloroquanil, Bigumalum)